Integrated BioPharma, Inc. (INBP)

Integrated BioPharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	3.62	1.68	1.32	0.33	0.21
Short-Term Investments	-	-	-	0.01	0.07
Cash & Short-Term Investments	3.62	1.68	1.32	0.34	0.28
Cash Growth	115.56%	27.43%	283.67%	23.83%	-48.32%
Receivables	5.43	4.67	4.51	4.89	5.78
Inventory	9.36	11.24	10.26	11.06	11.7
Other Current Assets	0.36	0.29	0.28	0.34	0.25
Total Current Assets	18.76	17.88	16.37	16.63	18
Property, Plant & Equipment	2.75	3.68	4.28	3.78	4.11
Long-Term Deferred Tax Assets	3.34	4.6	4.73	4.8	3.27
Other Long-Term Assets	0.05	0.06	0.06	0.05	0.07
Total Assets	24.9	26.21	25.43	25.25	25.44
Accounts Payable	2.27	2.51	2.27	3.21	3.5
Accrued Expenses	1.3	2.66	1.63	1.41	1.61
Short-Term Debt	-	-	-	0.1	2.17
Current Portion of Long-Term Debt	-	-	-	0.03	1.46
Current Portion of Leases	0.68	0.95	0.93	0.51	0.5
Total Current Liabilities	4.25	6.12	4.83	5.26	9.24
Long-Term Debt	-	-	-	0.05	-
Long-Term Leases	0.34	0.85	1.74	1.36	1.87
Total Liabilities	4.58	6.97	6.57	6.68	11.11
Common Stock	0.06	0.06	0.06	0.06	0.06
Additional Paid-In Capital	51.77	51.5	51.24	50.92	50.52
Retained Earnings	-31.42	-32.23	-32.34	-32.31	-36.14
Treasury Stock	-0.1	-0.1	-0.1	-0.1	-0.1
Shareholders' Equity	20.32	19.24	18.86	18.58	14.33
Total Liabilities & Equity	24.9	26.21	25.43	25.25	25.44
Total Debt	1.02	1.8	2.67	2.06	6
Net Cash (Debt)	2.6	-0.12	-1.36	-1.71	-5.72
Net Cash Per Share	0.08	-0.00	-0.05	-0.05	-0.18
Filing Date Shares Outstanding	31.06	30.1	29.95	29.95	29.82
Total Common Shares Outstanding	31.06	30.1	29.95	29.95	29.8
Working Capital	14.52	11.75	11.54	11.36	8.76
Book Value Per Share	0.65	0.64	0.63	0.62	0.48
Tangible Book Value	20.32	19.24	18.86	18.58	14.33
Tangible Book Value Per Share	0.65	0.64	0.63	0.62	0.48
Land	1.25	1.25	1.25	1.25	1.25
Machinery	7.25	7.11	6.8	6.73	6.42
Leasehold Improvements	1.41	1.34	1.37	1.37	1.36

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.